OQROGet OQRO Pro
Politician trade (House)

AbbVie (ABBV)Rep. Robert J. Wittman (VA01) disclosed a sale $1K–$15K

Rep. Robert J. Wittman (VA01) disclosed a sale of AbbVie in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
21 days
Disclosure lag
Traded
Sep 28, 2023
Disclosed
Oct 19, 2023

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 12, 2020CongressDisclosed purchase of ABBV — reported range $15,001 - $50,000
  2. Nov 16, 2020CongressDisclosed purchase of ABBV — reported range $15,001 - $50,000
  3. Jul 12, 2023CongressDisclosed sale of ABBV — reported range $50,001 - $100,000
  4. Jul 14, 2023CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  5. Jul 27, 2023CongressDisclosed partial sale of ABBV — reported range $1,001 - $15,000
  6. Aug 7, 2023CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
  7. Aug 14, 2023CongressDisclosed sale of ABBV — reported range $15,001 - $50,000
  8. Aug 30, 2023CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
  9. Sep 6, 2023CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
  10. Sep 8, 2023CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  11. Sep 26, 2023CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
  12. Sep 28, 2023 · this disclosureCongressDisclosed sale of ABBV — reported range $1,001 - $15,000

What came next

  1. Oct 17, 2023FDARecall: Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11
  2. Oct 17, 2023CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
  3. Oct 24, 2023CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  4. Nov 8, 2023CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  5. Nov 20, 2023CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  6. Dec 8, 2023CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  7. Jan 26, 2024FDAFDA drug approval: Avycaz
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for AbbVie

For AbbVie, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 130 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABBV page.

Other recent filings by Rep. Robert J. Wittman (VA01)

The full history of Rep. Robert J. Wittman (VA01) is on the profile page.

How this filing works

Other disclosures at AbbVie

Everything OQRO holds on this company is on its ABBV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data